Skip to main content
TCRT
NASDAQ Life Sciences

Alaunos' Oral Obesity Drug ALN1003 Shows Positive Preclinical Proof-of-Concept Data

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.01
Mkt Cap
$7.12M
52W Low
$1.314
52W High
$6.2
52W Position info
129% above low
Off High info
51% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

TCRT has more than doubled off its 52-week low of $1.314.

Summary

Alaunos Therapeutics announced positive preclinical proof-of-concept data for ALN1003, its differentiated non-hormonal oral treatment for obesity and related metabolic disorders. The data demonstrated dose-related weight loss, improved body composition, reduced liver weight, and better liver injury biomarkers, with ALN1003 being generally well tolerated. This is a highly significant development for the small biotech, validating its pipeline in a potentially massive market. While the company noted its cash runway extends only into Q2 2026, this positive data could be a crucial catalyst for future financing or partnership opportunities. Investors will now watch for further clinical trial progression and updates on the company's financial strategy.

At the time of this announcement, TCRT was trading at $3.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $1.31 to $6.20. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

TCRT - Latest Insights

TCRT
Nov 13, 2026, 5:30 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.56
Real-time Price: $1.64 info
Change: +$0.080 (+5%) info
Market Cap: $6.902M info
TCRT
Nov 12, 2026, 7:49 PM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.64 info
Change: +$0.0401 (+3%) info
Market Cap: $6.902M info
TCRT
Oct 23, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $1.64 info
Change: -$0.810 (-33%) info
Market Cap: $6.902M info
TCRT
Oct 21, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $1.64 info
Change: -$1.51 (-48%) info
Market Cap: $6.902M info
TCRT
Oct 15, 2026, 7:55 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $1.64 info
Change: -$1.24 (-43%) info
Market Cap: $6.902M info